AJPB
Issue:
May/June 2014
Volume:
6
Number:
3
Drug Trends
Paige Berger
As we shift the healthcare paradigm, new ways to lower costs and improve adherence are worth another look.
From the Editor
Jan E. Berger, MD, MJā€”Editor-in-Chief
There are 10 steps that need to be taken to help payers more adequately address the problem of inappropriate prescribing of pain medications.
Original Research
Jan Berger, MD, MJ; Louis L. Brunetti, MD; Robert DaSilva, RPh; Shareh O. Ghani, MD; Kevin Hirsch, MD; Mumtaz Ibrahim, MD; Michael Kobernick, MD, MS, FAAEM, FAAFP; Robin J. Richardson, RPh; Scott Schnuckle; Justin Weiss, PharmD; and Richard Bankowitz, MD, MBA, FACP
Executive-level pharmacy leaders in US managed care organizations identify how healthcare reform is driving changes in pharmacy benefit management.
Qian Cai, MS, MSPH; Chureen Carter, PharmD, MS; Azza AbuDagga, PhD, MHA; Brad Schenkel, MS; Megan Jones, PharmD, MPA; and Hiangkiat Tan, BPharm, MS
This study is an evaluation of the dosing patterns of ustekinumab among patients with psoriasis in a real-world setting.
Patient Advocacy
Myrl Weinberg, FASAE, CAE
Congress has passed a law designed to get advanced diagnostic tests to patients more quickly and to promote personalized care for patients.
Specialty Healthcare Benefits Council
Stephen Altenburger, PharmD; and Maureen Miller, MPH, BSN
The 2014 CMS Coverage Determination and Appeals audit will challenge plans providing Medicare Part D services, and could lead to a cascading impact much larger than audit failure alone.